Pro Medicus is a healthcare IT company specializing in radiology imaging software... Show more
PMCUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where PMCUF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where PMCUF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PMCUF advanced for three days, in of 84 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 286 cases where PMCUF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for PMCUF moved out of overbought territory on July 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PMCUF as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PMCUF turned negative on July 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMCUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PMCUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PMCUF's P/B Ratio (149.254) is very high in comparison to the industry average of (11.231). PMCUF's P/E Ratio (337.435) is considerably higher than the industry average of (80.335). PMCUF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.407). Dividend Yield (0.002) settles around the average of (0.063) among similar stocks. P/S Ratio (178.571) is also within normal values, averaging (85.405).
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, PMCUF has been loosely correlated with BMBL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PMCUF jumps, then BMBL could also see price increases.
Ticker / NAME | Correlation To PMCUF | 1D Price Change % | ||
---|---|---|---|---|
PMCUF | 100% | N/A | ||
BMBL - PMCUF | 34% Loosely correlated | -1.71% | ||
OCLCF - PMCUF | 31% Poorly correlated | N/A | ||
TMSNY - PMCUF | 30% Poorly correlated | -0.91% | ||
DAVA - PMCUF | 27% Poorly correlated | +2.55% | ||
FIVN - PMCUF | 24% Poorly correlated | -3.56% | ||
More |
Ticker / NAME | Correlation To PMCUF | 1D Price Change % |
---|---|---|
PMCUF | 100% | N/A |
Services to the Health Industry industry (97 stocks) | 10% Poorly correlated | +0.84% |
Health Services industry (442 stocks) | 5% Poorly correlated | +0.88% |